AOD 9604: what does it do? Learn how this growth hormone fragment affects fat metabolism, what studies show, dosing claims, and general safety.
AOD 9604 is a synthetic peptide fragment of human growth hormone that is studied mainly for one thing: breaking down stored fat. Laboratory and animal research shows it mimics the fat-mobilizing part of growth hormone while largely avoiding the growth and blood-sugar effects. AOD 9604 is not FDA-approved for human use in the United States and is sold only as a research chemical.
What Is AOD 9604?
AOD 9604 is a 16-amino-acid piece of the human growth hormone molecule, commonly labeled hGH 176-191 or hGH fragment 176-191. Researchers trimmed the full hormone down to the region linked to fat metabolism, hoping to keep the fat-loss signal without the side effects of the whole hormone.
It also appears in the literature as AOD9604, and it is grouped with other metabolic peptides in research settings. Studies have looked at it in animals, in human obesity trials, and in early cartilage research.
- Compound type: Synthetic growth hormone-derived peptide fragment
- Main research interest: Fat metabolism and body-fat reduction
- Regulatory status in the US: Not approved for human use
- Sports status: Prohibited by the World Anti-Doping Agency
What Does AOD 9604 Do in the Body?
AOD 9604 acts on fat cells directly instead of through the full growth hormone pathway. Its two most studied actions are increasing lipolysis, the breakdown of stored fat, and reducing lipogenesis, the creation of new fat.
Fat breakdown and fat storage
In animal models, AOD 9604 increased the release of fatty acids from fat tissue and lowered the rate at which the body stored new fat. Researchers describe this as a targeted version of growth hormone's metabolic activity.
That mechanism is the basis of nearly every product claim about the peptide. If you are wondering what is aod 9604 used for, the accurate answer is fat-loss research — not muscle building, not injury recovery, and not hormone replacement.
IGF-1, blood sugar, and growth
Full growth hormone raises IGF-1, influences insulin sensitivity, and drives tissue growth. AOD 9604 does not appear to do those things to a meaningful degree in published studies, which is the main reason scientists were interested in it.
Cartilage and joint research
Some laboratory work has explored whether the peptide supports cartilage repair. That research is early and mostly preclinical, so it should not be treated as an established joint treatment.
What Does the Human Research Actually Show?
AOD 9604 reached Phase IIb human trials for obesity in the mid-2000s. Weight loss in those trials was modest, and the developer eventually discontinued the obesity program. So does aod 9604 actually work? In animals, the effects are consistent. In humans, they have been too weak to earn approval from any regulator.
That gap matters. A compound can be biologically active and still fail to produce meaningful results in people at tolerable doses.
| Feature | AOD 9604 | Full growth hormone (somatropin) |
|---|---|---|
| Structure | 16-amino-acid fragment (hGH 176-191) | Complete 191-amino-acid hormone |
| Primary studied effect | Fat breakdown and blocked fat storage | Growth, IGF-1 production, metabolism |
| Effect on IGF-1 | Little to none reported | Significant increase |
| Effect on blood sugar | No clear effect in trials | Can reduce insulin sensitivity |
| FDA-approved for human use? | No | Yes, for specific diagnosed conditions |
| WADA status | Prohibited | Prohibited |
Dosing, Timing, and Realistic Expectations
No standard human dose of AOD 9604 exists. Trials used different amounts and schedules, and none produced results strong enough to support a clinical recommendation.
People who use research peptides often share injection schedules and cycle lengths online. Those numbers come from forum posts and vendor marketing, not from medical guidance or trial data.
Timelines are equally unclear. When people ask how long does aod 9604 take to work, the honest answer is that no reliable human timeline has been established, and trial results stayed small even after months of use.
How AOD 9604 Is Handled in Practice
AOD 9604 ships as a lyophilized powder that has to be reconstituted before use. Because of that, many people search what does bac water do for peptides; the short answer is that bacteriostatic water contains benzyl alcohol, which slows bacterial growth in a vial that gets punctured repeatedly.
Reconstituting and injecting any research chemical carries real risks, including contamination, inaccurate dosing, and injection-site reactions. Sterile technique and a clean supply chain are not guaranteed in the gray market.
People comparing fat-metabolism compounds also ask l carnitine what does it do, since carnitine helps shuttle fatty acids into mitochondria for energy. The two are not equivalent: carnitine is a nutrient with a regulated supplement market, while AOD 9604 is an unapproved research peptide.
Safety and Legal Considerations
AOD 9604 is not approved by the FDA for any human use, and products sold for research use only are not manufactured to pharmaceutical standards. Purity, sterility, and actual content can vary from vial to vial.
- Reported side effects in human trials were generally mild, but those trials were small and short.
- Long-term safety data in humans does not exist.
- Injection risks include infection, irritation, and dosing errors.
- AOD 9604 is banned in sport, and a positive test can end a career.
Anyone considering it should talk with a licensed healthcare professional rather than rely on vendor claims or forum advice. No peptide sold online is a substitute for medical care.
Key Takeaways
- AOD 9604 is a growth hormone fragment studied for fat metabolism, not muscle growth.
- Animal studies show consistent fat loss, but human trial results have been modest.
- AOD 9604 is not FDA-approved for human use and is prohibited by WADA.
- No standard human dose or reliable timeline has been established for AOD 9604.
- Quality and sterility of research-grade peptides are not guaranteed.
Frequently Asked Questions
Does AOD 9604 actually work for weight loss?
Animal studies show that AOD 9604 consistently increases fat breakdown, but human obesity trials produced only modest weight loss and the development program was discontinued. There is no strong clinical evidence that it causes meaningful fat loss in people.
Is AOD 9604 FDA-approved?
No. AOD 9604 is not FDA-approved for any human use, and it is sold as a research chemical rather than a medication. It is also on the World Anti-Doping Agency's prohibited list.
What are the side effects of AOD 9604?
Human trials reported mostly mild reactions, and those trials were short, so long-term safety is unknown. Injection-related risks such as infection and irritation are a concern with any unapproved research peptide.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.